Universal Pictures is banking on horror fans receiving Black Phone 2 with open arms on October 17th. Following up on the surprise 2022 hit based on a novel by Joe Hill (son of Stephen King), Scott Derrickson is back directing. Ethan Hawke reprises his role as serial killer The Grabber alongside Mason Thameas, Madeleine McGraw, Demián Bechir, Miguel Mora, Jeremy Davies and Arianna Rivas.
Scary movies have been hot properties in 2025 and there should be enough goodwill left over from the original for this to solidly perform. Reviews are mostly positive with 81% on Rotten Tomatoes and a 71 Metacritic (pretty much right where part 1 landed).
I wouldn’t be surprised if this premiere plays out similar to Smile 2. That sequel opened on the same weekend last year with $23 million and that just edged the $22.6 million earned by its predecessor. The first Phone dialed up $23.6 million for starters and I’ll gave 2 slightly more.
Black Phone 2 opening weekend prediction: $25.5 million
Dwayne Johnson and Chris Evans headline this weekend’s sole wide release with the Christmas action comedy Red One. It looks to dominate the charts with an eye on a lengthy holiday run. You can peruse my detailed prediction post on it here:
Early word-of-mouth is a bit troubling with a 30% Rotten Tomatoes score. I don’t think it gets to the top end of its anticipated range ($40 million). A mid to high 20s output would be considered a cold opening, but families may wait until later in the month to check it out.
Holdovers should all drop a notch as we await heavy hitters like Wicked, Gladiator II, and Moana 2. Venom: The Last Dance should dip to second after three weeks atop the charts. There’s a decent chance that The Best Christmas Pageant Ever stays in third as it might have a better sophomore hold than Heretic. The Wild Robot should round out the top five and here’s how I envision it breaking down:
1. Red One
Predicted Gross: $27.6 million
2. Venom: The Last Dance
Predicted Gross: $10.2 million
3. The Best Christmas Pageant Ever
Predicted Gross: $7.6 million
4. Heretic
Predicted Gross: $6.3 million
5. The Wild Robot
Predicted Gross: $5.5 million
Box Office Results (November 8-10)
Tom Hardy’s loopy third take on his comic book creation was #1 for a third frame as Venom: The Last Dance repeated with $15.9 million. That’s a bit ahead of my $14.3 million projection as the total is $114 million thus far. It won’t match its two predecessors, but it has posted solid holds weekend to weekend.
Horror thriller Heretic with Hugh Grant came in right where it was forecasted in second with $11 million (I said $11.2 million). Despite strong reviews, this certainly didn’t over perform and a so-so C+ Cinemascore could mean it fades fairly quickly.
Yuletide dramedy The Best Christmas Pageant Ever was third with $10.7 million, outpacing my $8 million call. This will hope for smallish declines as the festive season is just underway.
The Wild Robot was fourth with $6.6 million, edging my $5.5 million prediction. The potential Animated Feature Oscar frontrunner has collected $130 million after seven weeks.
Smile 2 was fifth with $5.1 million (I went with $4.4 million) as the horror sequel sits at $60 million in its four weeks of play.
Critically acclaimed horror thriller Heretic and holiday family dramedy The Best Christmas Pageant Ever will both attempt to keep Venom: The Last Dance from a third weekend in first place. You can peruse my detailed prediction posts on the newbies here:
Heretic finds Hugh Grant dipping into scary territory and my low double digits estimate puts it in range with the September start of Speak No Evil. That’s likely good for second place.
I’ve got Christmas in third in the high single digits though its chances of over performing exist. I also think it might experience low declines as the holidays approach and get off to a relatively slow start.
My projections on the two openers does indeed leave Venom atop the charts for a third frame assuming it drops in the mid 40s. Holdovers The Wild Robot and Smile 2 should round out the high five and here’s how I have it playing out:
1. Venom: The Last Dance
Predicted Gross: $14.3 million
2. Heretic
Predicted Gross: $11.2 million
3. The Best Christmas Pageant Ever
Predicted Gross: $8 million
4. The Wild Robot
Predicted Gross: $5.6 million
5. Smile 2
Predicted Gross: $4.4 million
Box Office Results (November 1-3)
November started off in multiplexes with October product holding steadier than my forecasts. Venom: The Last Dance is the prime example as it declined only 49% in weekend #2 with $25.9 million. I was much lower at $17.3 million. That’s a bit of a surprise considering predecessor Let There Be Carnage plummeted in the mid 60s. Of course, it’s worth noting that Dance opened with nearly $40 million less than Carnage.
The Wild Robot was second with $7.4 million as it managed to rise 9% and blast past my $5 million call. The animated pic has amassed $121 million after six weeks.
Smile 2 was third with $6.7 million and that’s wider than my $5.6 million take. The horror sequel is up to $52 million after three frames.
Oscar hopeful Conclave eased a mere 24% in fourth with $5 million (I said $4.2 million) for $14 million in two outings.
Finally, Robert Zemeckis’s Here, which reunites his Forrest Gump leads Tom Hanks and Robin Wright, stumbled with critics and audiences. The fifth place showing netted $4.8 million. My prediction? $4.8 million!
Robert Zemeckis reunites with his Forrest Gump leads Tom Hanks and Robin Wright some 30 years after that Best Picture recipient with the family drama Here this weekend. My detailed prediction post on the newcomer can be accessed here:
Here is likely to be the sole newbie to place in the top five. Unlike Gump, there’s no awards buzz for this. A debut in the mid single digits could mean anywhere from second to fifth.
Tom Hardy’s third and reportedly final go-round in The Last Dance had a subpar start (more on that below). With a troubling B- Cinemascore, a 60 percent plus percentage drop appears inevitable. That should mean mid or high teens for an unremarkable repeat performance in 1st place.
Holdovers Smile 2, The Wild Robot, and Conclave should fill out the rest of the high five and here’s how I have it playing out:
1. Venom: The Last Dance
Predicted Gross: $17.3 million
2. Smile 2
Predicted Gross: $5.6 million
3. The Wild Robot
Predicted Gross: $5 million
4. Here
Predicted Gross: $4.8 million
5. Conclave
Predicted Gross: $4.2 million
Box Office Results (October 25-27)
As mentioned, viewers were not grooving to Venom: The Last Dance. The comic book based sequel set in Sony’s Spider-Man Universe took in $51 million. That’s under my $62.3 million take and well below 2018’s Venom ($80 million) and 2021 follow-up Let There Be Carnage at $90 million. Crowds have clearly soured on the franchise.
The news wasn’t great for Smile 2 either. The horror sequel was second with $9.5 million and that represents a 59% plummet. Its 2022 predecessor only experienced an 18% decline in weekend #2. While I didn’t think that would occur, I had this pegged at $15.6 million during its follow-up frame.
The Wild Robot was third with $6.8 million compared to my $7.5 million call. The animated hit has taken in $111 million in five weeks.
Oscar hopeful Conclave with Ralph Fiennes was fourth with a better than anticipated $6.6 million. Edward Berger’s papal succession drama blew past my $4.8 million projection.
The Andrew Garfield/Florence Pugh romance We Live in Time added nearly 2000 screens and was fifth with $4.8 million. I incorrectly had it outside the top five as its total reached $11 million.
Finally, Terrifier 3 was sixth with $4.7 million (I said $5.4 million) for a robust $44 million in three weeks.
Tom Hardy is back in the threequel Venom: The Last Dance while awards hopeful Conclave also debuts Friday. You can peruse my detailed prediction posts on the weekend’s newcomers here:
Hardy’s latest go-round as the comic book symbiote will easily dominate the charts. Yet I’m not bullish that The Last Dance will top the openings of predecessors Venom from 2018 ($80 million) and 2021’s Venom: Let There Be Carnage ($90 million). I have it in the low to mid 60s.
Conclave is expected to nab a Best Picture nomination. Edward Berger’s follow-up to All Quiet on the Western Front may have to settle for a mid single digits start that should put it in fourth or fifth place.
As for holdovers, Smile 2 may benefit from its genre in weekend #2 as horror fans seek content. The first Smile rode a wave of loud buzz to a startling 18% decline in its second frame. I’d be surprised if the sequel sees that, but mid to high 30s seems feasible. The Wild Robot and Terrifier 3 should fill out the remainder of the high five.
Here’s how I see it playing out:
1. Venom: The Last Dance
Predicted Gross: $62.3 million
2. Smile 2
Predicted Gross: $15.6 million
3. The Wild Robot
Predicted Gross: $7.5 million
4. Terrifier 3
Predicted Gross: $5.4 million
5. Conclave
Predicted Gross: $4.8 million
Box Office Results (October 18-20)
Smile 2 was barely able to open wider than part 1 at $23 million. The original hit $22.6 million two years later. I had this making slightly more at $27 million. That’s a fair result though (as mentioned above) I wouldn’t expect this to have quite the sturdy legs of what came before.
The Wild Robot held in second with $10 million, on par with my $10.7 million forecast. The animated adventure is now north of nine digits after four weeks with $101 million.
Terrifier 3 slid from first to third with $9.3 million, in line with my $9.8 million call. The $38 million total in ten days is quite a feat considering the reported teensy $2 million price tag.
Beetlejuice Beetlejuice was fourth with $5 million (I went with $5.8 million) for a seven-week haul of $283 million and $300 million potentially in its domestic sights.
Finally, the Andrew Garfield/Florence Pugh rom dram We Live in Time expanded to just under 1000 venues and posted $4.1 million. I was close with $4.3 million. That brought the overall tally to $4.5 million.
Smile 2 looks to make horror fans happy this weekend while the Andrew Garfield and Florence Pugh romantic drama We Live in Time debuts. You can peruse my detailed prediction posts on them here:
Likely building upon the goodwill from its predecessor two years ago, Smile 2 should outpace the $22 million that Smile opened wide with. My mid to high 20s estimate puts it easily out front.
Time is hitting just 1000 venues and I’m projecting mid single digits before it expands even wider on October 25th.
Terrifier 3 got off to a terrific start (more on that below). Projecting its sophomore fall is tricky. I would think the unrated horror threequel might be front loaded, but I’m not sure it drops over 60%. It’s actually theaters so it may only decline around 50% and that’s good for a horror flick of this nature. That should put it in third as I foresee The Wild Robot only easing in the mid 20s and staying in second. A similar meager decrease for Beetlejuice Beetlejuice should keep it in the top 5 in its seventh frame. Joker: Folie à Deux may manage fifth place though it should see another calamitous percentage fall. Yet I wouldn’t be surprised if Transformers One manages to rise the five spot.
Here’s how I see the top 6 playing out:
1. Smile 2
Predicted Gross: $27 million
2. The Wild Robot
Predicted Gross: $10.7 million
3. Terrifier 3
Predicted Gross: $9.8 million
4. Beetlejuice Beetlejuice
Predicted Gross: $5.8 million
5. We Live in Time
Predicted Gross: $4.3 million
Box Office Results (October 11-13)
Please note that Joker: Folie à Deux is not listed in my top 5 for its third go-round due to a historically awful sophomore weekend plummet. We’ll get to that in a second, but let’s focus on the other big story for now. Terrifier 3 wowed prognosticators with $18.8 million, ahead of my $14.4 million call. With a reported budget of $5 million, the grisly Art the Clown Christmas bloodbath solidified its franchise bonafides. You can expect a fourth cut in the near future.
The Wild Robot held in second with $14 million and surpassed my $11.7 million prediction. In its three weeks in multiplexes, the DreamWorks Animation adventure has amassed $84 million as it flies to nine digit territory.
Beetlejuice Beetlejuice was third with $7.3 million (I said $6.7 million) for a six-week tally of $275 million as it looks to scare up $300M+ domestically.
Joker: Folie à Deux, after a disastrous enough premiere, was down an embarrassing 81% in fourth with $7 million. I was more generous in thinking it would only go down 75% with $9.5 million. The lambasted sequel has taken in $51 million in ten days and will struggle to reach $75 million stateside. As a reminder, its 2019 predecessor made $335 million in the U.S. and Canada and over one billion worldwide.
A slew of newcomers that didn’t star Art the Clown failed to fill seats. Lego themed Pharrell documentary Piece by Piece was fifth with $3.8 million compared to my $5.4 million projection.
Holdover Transformers One was sixth with $3.7 million for a muted $52 million in four weeks. I did not do an estimate for the animated Hasbro title.
Saturday Night, Jason Reitman’s recounting of the lead-up to SNL’s first episode in 1975, was seventh with a discouraging $3.4 million. I had it pegged in fourth with $7.8 million. SHAMELESS PLUG ALERT: check out the homepage on my blog to see my Top 50 SNL Cast Members of All Time posts. At press time, I’ve written entries for numbers 50-43 and they are being uploaded on a daily(ish) basis.
Manga sequel My Hero Academia: You’re Next was eighth with a meh $3 million, just over half of my $5.9 million prediction.
Finally, The Apprentice stumbled in 10th with $1.6 million (I went with $2.4 million). The story of Donald Trump rising to prominence in the 1980s did not attract curious onlookers.
Paramount is looking for happy results when their horror sequel Smile 2 opens wide on October 18th. Parker Finn is back in the director’s seat two years after helming the original. Naomi Scott, Rosemarie DeWitt, Kyle Gallner, Lukas Gage, Miles Gutierrez-Riley, Peter Jacobson, Raul Castillo, Dylan Gelula, and Ray Nicholson are among the cast.
Back in 2022, Smile turned into an unexpected blockbuster. With a reported price tag of only $17 million, it earned $105 million domestically and another $110M+ elsewhere. A sequel was rapidly commissioned.
With an advantageous October release date and goodwill left over from part 1, Smile 2 could outdo the $22.6 million that its predecessor began with. Whether it eventually reaches the nine digit stateside take of Smile may depend on its quality.
All My Life... I Wanted To Be A Blogster 